1. Dehydroascorbic acid sensitizes cancer cells to system x c - inhibition-induced ferroptosis by promoting lipid droplet peroxidation.
- Author
-
Ferrada L, Barahona MJ, Vera M, Stockwell BR, and Nualart F
- Subjects
- Humans, Dehydroascorbic Acid pharmacology, Lipid Droplets, Cell Death, Lipid Peroxidation, Ferroptosis, Neoplasms
- Abstract
Since the discovery of ferroptosis, it has been postulated that this type of cell death could be utilized in treatments for cancer. Unfortunately, several highly aggressive tumor models are resistant to the pharmacological induction of ferroptosis. However, with the use of combined therapies, it is possible to recover sensitivity to ferroptosis in certain cellular models. Here, we discovered that co-treatment with the metabolically stable ferroptosis inducer imidazole ketone erastin (IKE) and the oxidized form of vitamin C, dehydroascorbic acid (DHAA), is a powerful therapy that induces ferroptosis in tumor cells previously resistant to IKE-induced ferroptosis. We determined that DHAA and IKE + DHAA delocalize and deplete GPX4 in tumor cells, specifically inducing lipid droplet peroxidation, which leads to ferroptosis. Moreover, in vivo, IKE + DHAA has high efficacy with regard to the eradication of highly aggressive tumors such as glioblastomas. Thus, the use of IKE + DHAA could be an effective and safe therapy for the eradication of difficult-to-treat cancers., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF